An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment
Kristin DePeaux(Princeton University), Greg M. Delgoffe(University of Pittsburgh), Dayana B. Rivadeneira(University of Pittsburgh), Victoria Dean(University of Pittsburgh), Konstantinos Lontos(The University of Texas MD Anderson Cancer Center), T. J. Yao(University of Pittsburgh), Andrew P. Hinck(University of Pittsburgh), McLane J. Watson(Vanderbilt University Medical Center), Drew N. Wilfahrt(UPMC Hillman Cancer Center), Łukasz Wieteska(University of Leeds), Cynthia S. Hinck(University of Pittsburgh), William G. Gunn(University of Pittsburgh), Stephen H. Thorne
Cited by 44
Related Papers
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
|Nature Immunology|2011|1.1k
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
|The Journal of Experimental Medicine|2018|302
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
|Nature Immunology|2022|254
Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism
|Nature Immunology|2024|134
Metabolic waypoints during T cell differentiation
|Nature Immunology|2024|83